Stevanato (STVN) | Financial Analysis & Statements
Stevanato Group S.p.A. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
346.5M
Gross Profit
106.9M
30.85%
Operating Income
70.1M
20.23%
Net Income
47.6M
13.72%
Balance Sheet Metrics
Total Assets
2.5B
Total Liabilities
1.1B
Shareholders Equity
1.5B
Debt to Equity
0.71
Cash Flow Metrics
Operating Cash Flow
141.6M
Free Cash Flow
-485.0K
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Stevanato Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.2B | 1.1B | 1.1B | 983.7M | 843.9M |
| Cost of Goods Sold | 842.4M | 801.7M | 745.5M | 663.9M | 578.5M |
| Gross Profit | 343.9M | 302.3M | 339.9M | 319.8M | 265.4M |
| Gross Margin % | 29.0% | 27.4% | 31.3% | 32.5% | 31.4% |
| Operating Expenses | |||||
| Research & Development | 25.4M | 31.7M | 35.7M | 34.4M | 29.6M |
| Selling, General & Administrative | 119.1M | 118.6M | 113.9M | 111.8M | 83.0M |
| Other Operating Expenses | -8.2M | -9.1M | -10.4M | -18.8M | -9.4M |
| Total Operating Expenses | 136.3M | 141.2M | 139.2M | 127.4M | 103.2M |
| Operating Income | 198.8M | 161.1M | 200.7M | 192.4M | 162.2M |
| Operating Margin % | 16.8% | 14.6% | 18.5% | 19.6% | 19.2% |
| Non-Operating Items | |||||
| Interest Income | 1.0M | 1.7M | 792.0K | 648.0K | 548.0K |
| Interest Expense | 6.5M | 6.9M | 4.3M | 3.9M | 4.9M |
| Other Non-Operating Income | -3.9M | 5.0M | -7.4M | -1.4M | 7.8M |
| Pre-tax Income | 189.1M | 160.3M | 189.6M | 187.6M | 165.7M |
| Income Tax | 49.3M | 42.5M | 43.9M | 44.6M | 31.4M |
| Effective Tax Rate % | 26.1% | 26.5% | 23.1% | 23.8% | 19.0% |
| Net Income | 139.8M | 117.8M | 145.7M | 143.0M | 134.3M |
| Net Margin % | 11.8% | 10.7% | 13.4% | 14.5% | 15.9% |
| Key Metrics | |||||
| EBITDA | 288.1M | 242.8M | 279.8M | 257.8M | 219.6M |
| EPS (Basic) | $0.51 | $0.43 | $0.55 | $0.54 | $0.53 |
| EPS (Diluted) | $0.51 | $0.43 | $0.55 | $0.54 | $0.53 |
| Basic Shares Outstanding | 272952877 | 271100000 | 245542355 | 252518513 | 241070753 |
| Diluted Shares Outstanding | 272952877 | 271100000 | 245542355 | 252518513 | 241070753 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Stevanato Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 130.6M | 98.3M | 69.6M | 228.7M | 411.0M |
| Short-term Investments | - | 0 | 749.0K | 27.9M | 27.2M |
| Accounts Receivable | 302.7M | 296.0M | 301.8M | 212.7M | 165.3M |
| Inventory | 268.2M | 245.2M | 255.3M | 213.3M | 148.9M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 943.4M | 880.1M | 861.9M | 845.8M | 866.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 122.4M | 108.8M | 90.1M | 78.7M | 69.8M |
| Goodwill | 136.8M | 133.6M | 131.0M | 126.6M | 126.4M |
| Intangible Assets | 36.9M | 33.6M | 31.0M | 32.2M | 31.9M |
| Long-term Investments | 340.0K | 0 | 577.0K | 2.8M | 0 |
| Other Non-Current Assets | 103.9M | 95.3M | 76.3M | 69.2M | 56.3M |
| Total Non-Current Assets | 1.6B | 1.4B | 1.2B | 813.9M | 552.9M |
| Total Assets | 2.5B | 2.3B | 2.1B | 1.7B | 1.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 263.3M | 231.0M | 277.8M | 239.2M | 164.8M |
| Short-term Debt | 121.7M | 111.9M | 141.4M | 70.0M | 42.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 9.2M | 11.3M | 10.1M | 8.7M | 13.6M |
| Total Current Liabilities | 535.9M | 477.5M | 574.4M | 462.5M | 338.6M |
| Non-Current Liabilities | |||||
| Long-term Debt | 347.2M | 317.0M | 255.2M | 148.4M | 201.6M |
| Deferred Tax Liabilities | 13.3M | 12.6M | 9.6M | 21.0M | 19.1M |
| Other Non-Current Liabilities | 52.2M | 62.7M | 48.5M | 18.1M | 2.5M |
| Total Non-Current Liabilities | 521.6M | 447.0M | 364.5M | 201.3M | 238.6M |
| Total Liabilities | 1.1B | 924.4M | 938.9M | 663.8M | 577.2M |
| Equity | |||||
| Common Stock | 22.2M | 22.2M | 21.7M | 21.7M | 21.7M |
| Retained Earnings | 990.4M | 863.4M | - | - | - |
| Treasury Stock | 27.1M | 27.1M | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.5B | 1.4B | 1.1B | 995.9M | 841.7M |
| Key Metrics | |||||
| Total Debt | 468.9M | 429.0M | 396.6M | 218.4M | 244.3M |
| Working Capital | 407.5M | 402.6M | 287.5M | 383.3M | 527.3M |
Balance Sheet Composition
Stevanato Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 189.1M | 160.3M | 189.6M | 187.6M | 165.7M |
| Depreciation & Amortization | 88.6M | 80.7M | 78.5M | 64.8M | 56.4M |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 50.6M | -17.4M | -102.5M | -117.7M | -41.6M |
| Operating Cash Flow | 349.1M | 222.5M | 182.3M | 141.7M | 175.8M |
| Investing Activities | |||||
| Capital Expenditures | -261.9M | -299.5M | -432.7M | -234.9M | -106.5M |
| Acquisitions | 0 | -175.0K | -3.6M | 0 | 14.8M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | 31.0K | 773.0K |
| Investing Cash Flow | -261.9M | -299.6M | -408.3M | -234.9M | -90.9M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -14.7M | -14.5M | -14.3M | -13.5M | -11.2M |
| Debt Issuance | 150.0M | 190.2M | 247.5M | 13.2M | 8.0M |
| Debt Repayment | -113.2M | -162.3M | -74.9M | -44.2M | -128.2M |
| Financing Cash Flow | 22.1M | 183.2M | 158.0M | -44.5M | 254.8M |
| Free Cash Flow | 11.0M | -157.8M | -336.7M | -139.8M | 20.2M |
| Net Change in Cash | 109.3M | 106.1M | -68.0M | -137.7M | 339.7M |
Cash Flow Trend
Stevanato Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
25.58
Forward P/E
17.96
Price to Book
2.39
Price to Sales
3.53
PEG Ratio
-4.60
Profitability Ratios
Profit Margin
11.79%
Operating Margin
20.88%
Return on Equity
9.67%
Return on Assets
5.23%
Financial Health
Current Ratio
1.76
Debt to Equity
31.60
Beta
0.62
Per Share Data
EPS (TTM)
$0.60
Book Value per Share
$6.42
Revenue per Share
$4.35
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| STVN | 4.4B | 25.58 | 2.39 | 9.67% | 11.79% | 31.60 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Baxter International | 9.4B | 86.31 | 1.54 | -13.71% | -8.51% | 160.28 |
| AptarGroup | 8.0B | 21.10 | 2.99 | 15.10% | 10.40% | 57.10 |
| Repligen | 7.5B | 154.30 | 3.55 | 2.40% | 6.62% | 32.76 |
Financial data is updated regularly. All figures are in the company's reporting currency.






